PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of tobcontTobacco ControlVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Tob Control. 2003 March; 12(1): 21–27.
PMCID: PMC1759113

A meta-analysis of the efficacy of over-the-counter nicotine replacement

Abstract

Objective: To determine whether over-the-counter (OTC) nicotine replacement therapy (NRT) is pharmacologically efficacious, whether it produces abstinence rates similar to those in prescription settings, and to estimate the long term (that is, greater than six month) abstinence rate with OTC NRT.

Method: Systematic literature review.

Data sources: Medline, Psych Abstracts, bibliographies, requests of scientists.

Study selection: Studies comparing OTC NRT versus OTC placebo or studies comparing OTC NRT versus prescription NRT that reported abstinence rates and for which a full study report was available.

Data extraction: Two of the authors independently reviewed studies and compared results.

Data synthesis: Meta-analysis was performed by first testing for homogeneity across studies, then combining odds ratios (ORs) weighting by inverse variance and proportions weighting by study sample size.

Results: One OTC NRT versus OTC placebo nicotine gum study was excluded due to small sample size and different setting. The four remaining studies were randomised trials of nicotine versus placebo patch with ORs of 2.1–3.2. These outcomes were homogenous and when combined resulted in an OR favouring NRT of 2.5 (95% confidence interval (CI) 1.8 to 3.6). Among the two randomised and two non-randomised trials of OTC NRT versus prescription NRT, one small study had an OR of 0.3, two others had ORs of 1.0 and 1.4, and a fourth study had an OR of 3.6. These results were not homogenous; however, when combined via a random effects model the estimated OR was not less than 1.0—that is, OR 1.4 (95% CI 0.6 to 3.3). The long term (that is, greater than six months) quit rates for OTC NRT was 1% and 6% in two studies and 8–11% in five other studies. These results were not homogenous; however, when combined the estimated OR was 7% (95% CI 4% to 11%).

Conclusions: OTC NRT is pharmacologically efficacious and produces modest quit rates similar to that seen in real world prescription practice.

Full Text

The Full Text of this article is available as a PDF (182K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lichtenstein E, Hollis J. Patient referral to a smoking cessation program: who follows through? J Fam Pract. 1992 Jun;34(6):739–744. [PubMed]
  • Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications, 1996. MMWR Morb Mortal Wkly Rep. 1997 Sep 19;46(37):867–871. [PubMed]
  • Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA. 1999 Jan 6;281(1):72–76. [PubMed]
  • McNagny SE, Ahluwalia JS. Use of over-the-counter nicotine patch for smoking cessation: prudent or premature? JAMA. 1996 Aug 7;276(5):371–372. [PubMed]
  • Pierce JP, Gilpin E, Farkas AJ. Nicotine patch use in the general population: results from the 1993 California Tobacco Survey. J Natl Cancer Inst. 1995 Jan 18;87(2):87–93. [PubMed]
  • Shiffman S, Mason KM, Henningfield JE. Tobacco dependence treatments: review and prospectus. Annu Rev Public Health. 1998;19:335–358. [PubMed]
  • Thorndike Anne N, Biener Lois, Rigotti Nancy A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health. 2002 Mar;92(3):437–442. [PubMed]
  • Pierce John P, Gilpin Elizabeth A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002 Sep 11;288(10):1260–1264. [PubMed]
  • Hughes JR. Combining behavioral therapy and pharmacotherapy for smoking cessation: an update. NIDA Res Monogr. 1995;150:92–109. [PubMed]
  • Swartz SH, Ellsworth AJ, Curry SJ, Boyko EJ. Community patterns of transdermal nicotine use and provider counseling. J Gen Intern Med. 1995 Dec;10(12):656–662. [PubMed]
  • Johnson RE, Hollis JF, Stevens VJ, Woodson GT. Patterns of nicotine gum use in a health maintenance organization. DICP. 1991 Jul-Aug;25(7-8):730–735. [PubMed]
  • Johnson RE, Stevens VJ, Hollis JF, Woodson GT. Nicotine chewing gum use in the outpatient care setting. J Fam Pract. 1992 Jan;34(1):61–65. [PubMed]
  • Shiffman Saul, Gorsline Jane, Gorodetzky Charles W. Efficacy of over-the-counter nicotine patch. Nicotine Tob Res. 2002 Nov;4(4):477–483. [PubMed]
  • Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med. 1998 Nov-Dec;7(6):569–574. [PubMed]
  • Schneider NG, Jarvik ME, Forsythe AB, Read LL, Elliott ML, Schweiger A. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav. 1983;8(3):253–261. [PubMed]
  • Sønderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol. 1997 Feb 15;145(4):309–318. [PubMed]
  • Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M. Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials. Am J Public Health. 1999 Nov;89(11):1701–1707. [PubMed]
  • Shiffman Saul, Rolf Clyde N, Hellebusch Stephen J, Gorsline Jane, Gorodetzky Charles W, Chiang Yu-Kun, Schleusener Debra S, Di Marino Michael E. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction. 2002 May;97(5):505–516. [PubMed]
  • Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Kitchens K, Van Vunakis H. The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol. 1995 Jun;63(3):388–399. [PubMed]
  • Hughes JR, Wadland WC, Fenwick JW, Lewis J, Bickel WK. Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study. Prev Med. 1991 Jul;20(4):486–496. [PubMed]
  • Dey P, Foy R, Woodman M, Fullard B, Gibbs A. Should smoking cessation cost a packet? A pilot randomized controlled trial of the cost-effectiveness of distributing nicotine therapy free of charge. Br J Gen Pract. 1999 Feb;49(439):127–128. [PMC free article] [PubMed]
  • Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002 May;4(2):149–159. [PubMed]
  • Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psychol Bull. 1992 Jan;111(1):23–41. [PubMed]
  • Hughes JR. Comorbidity and smoking. Nicotine Tob Res. 1999;1 (Suppl 2):S149–S166. [PubMed]
  • State medicaid coverage for tobacco-dependence treatments--United States, 1998 and 2000. MMWR Morb Mortal Wkly Rep. 2001 Nov 9;50(44):979–982. [PubMed]
  • Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians. JAMA. 1998 Feb 25;279(8):604–608. [PubMed]
  • Russell MA, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Connor P. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ. 1993 May 15;306(6888):1308–1312. [PMC free article] [PubMed]
  • Cohen S, Lichtenstein E, Prochaska JO, Rossi JS, Gritz ER, Carr CR, Orleans CT, Schoenbach VJ, Biener L, Abrams D, et al. Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol. 1989 Nov;44(11):1355–1365. [PubMed]
  • Irvin JE, Brandon TH. The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res. 2000 Feb;2(1):79–84. [PubMed]
  • Hughes JR, Gulliver SB, Fenwick JW, Valliere WA, Cruser K, Pepper S, Shea P, Solomon LJ, Flynn BS. Smoking cessation among self-quitters. Health Psychol. 1992;11(5):331–334. [PubMed]
  • Shiffman S, Gitchell J, Pinney JM, Burton SL, Kemper KE, Lara EA. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997 Winter;6(4):306–310. [PMC free article] [PubMed]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group